Drug‐associated glaucoma: A real‐world study based on the <scp>Food and Drug Administration</scp> adverse event reporting system database
Preventing drug-associated glaucoma is more effective than treatment. Identifying the risk and drug-induced times of systemic and ophthalmic drugs can reduce occurrence risk. Clinical practitioners should be vigilant and inform patients of these risks.
Authors
- Jiaoyue Hu
- Dan Yan (ORCID: https://orcid.org/0000-0003-1819-538X)
- Shaopan Wang (ORCID: https://orcid.org/0000-0001-8044-8398)
- Shi‐Nan Wu (ORCID: https://orcid.org/0000-0002-6992-9059)
- Xiaohong Chen (ORCID: https://orcid.org/0000-0002-9797-8384)
- Yuqian Wang (ORCID: https://orcid.org/0009-0004-1592-1790)
- Wenying Guan (ORCID: https://orcid.org/0000-0002-5816-7351)
- Caihong Huang
- Zuguo Liu
Institutions
- Xiamen University (CN)
- First Affiliated Hospital of University of South China (CN)
- University of South China (CN)
Publication Details
- Journal
- Clinical and Experimental Ophthalmology
- Published
- 2024-10-25
- DOI
- https://doi.org/10.1111/ceo.14454
- Citations
- 21
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 11.31